Cell-Based Models of 'Cytokine Release Syndrome' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy
While chimeric antigen receptor (CAR) T cell therapy has shown promising outcomes among patients with hematologic malignancies, it has also been associated with undesirable side-effects such as cytokine release syndrome (CRS). CRS is triggered by CAR T-cell-based activation of monocytes, which are s...
Saved in:
Published in | Cells (Basel, Switzerland) Vol. 12; no. 21; p. 2581 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
01.11.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | While chimeric antigen receptor (CAR) T cell therapy has shown promising outcomes among patients with hematologic malignancies, it has also been associated with undesirable side-effects such as cytokine release syndrome (CRS). CRS is triggered by CAR T-cell-based activation of monocytes, which are stimulated via the CD40L-CD40R axis or via uptake of GM-CSF to secrete proinflammatory cytokines. Mouse models have been used to model CRS, but working with them is labor-intensive and they are not amenable to screening approaches. To overcome this challenge, we established two simple cell-based CRS in vitro models that entail the co-culturing of leukemic B cells with CD19-targeting CAR T cells and primary monocytes from the same donor. Upon antigen encounter, CAR T cells upregulated CD40L and released GM-CSF which in turn stimulated the monocytes to secrete IL-6. To endorse these models, we demonstrated that neutralizing antibodies or genetic disruption of the
and/or
loci in CAR T cells using CRISPR-Cas technology significantly reduced IL-6 secretion by bystander monocytes without affecting the cytolytic activity of the engineered lymphocytes in vitro. Overall, our cell-based models were able to recapitulate CRS in vitro, allowing us to validate mitigation strategies based on antibodies or genome editing. |
---|---|
AbstractList | While chimeric antigen receptor (CAR) T cell therapy has shown promising outcomes among patients with hematologic malignancies, it has also been associated with undesirable side-effects such as cytokine release syndrome (CRS). CRS is triggered by CAR T-cell-based activation of monocytes, which are stimulated via the CD40L–CD40R axis or via uptake of GM-CSF to secrete proinflammatory cytokines. Mouse models have been used to model CRS, but working with them is labor-intensive and they are not amenable to screening approaches. To overcome this challenge, we established two simple cell-based CRS in vitro models that entail the co-culturing of leukemic B cells with CD19-targeting CAR T cells and primary monocytes from the same donor. Upon antigen encounter, CAR T cells upregulated CD40L and released GM-CSF which in turn stimulated the monocytes to secrete IL-6. To endorse these models, we demonstrated that neutralizing antibodies or genetic disruption of the CD40L and/or CSF2 loci in CAR T cells using CRISPR-Cas technology significantly reduced IL-6 secretion by bystander monocytes without affecting the cytolytic activity of the engineered lymphocytes in vitro. Overall, our cell-based models were able to recapitulate CRS in vitro, allowing us to validate mitigation strategies based on antibodies or genome editing. While chimeric antigen receptor (CAR) T cell therapy has shown promising outcomes among patients with hematologic malignancies, it has also been associated with undesirable side-effects such as cytokine release syndrome (CRS). CRS is triggered by CAR T-cell-based activation of monocytes, which are stimulated via the CD40L-CD40R axis or via uptake of GM-CSF to secrete proinflammatory cytokines. Mouse models have been used to model CRS, but working with them is labor-intensive and they are not amenable to screening approaches. To overcome this challenge, we established two simple cell-based CRS in vitro models that entail the co-culturing of leukemic B cells with CD19-targeting CAR T cells and primary monocytes from the same donor. Upon antigen encounter, CAR T cells upregulated CD40L and released GM-CSF which in turn stimulated the monocytes to secrete IL-6. To endorse these models, we demonstrated that neutralizing antibodies or genetic disruption of the and/or loci in CAR T cells using CRISPR-Cas technology significantly reduced IL-6 secretion by bystander monocytes without affecting the cytolytic activity of the engineered lymphocytes in vitro. Overall, our cell-based models were able to recapitulate CRS in vitro, allowing us to validate mitigation strategies based on antibodies or genome editing. |
Audience | Academic |
Author | Rhiel, Manuel Patel, Vidisha Bhavesh Boerries, Melanie Cornu, Tatjana I Andrieux, Geoffroy Cathomen, Toni Dibas, Ala Alzubi, Jamal |
Author_xml | – sequence: 1 givenname: Ala orcidid: 0009-0003-0073-1313 surname: Dibas fullname: Dibas, Ala organization: Ph.D. Program, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany – sequence: 2 givenname: Manuel orcidid: 0000-0003-0741-2780 surname: Rhiel fullname: Rhiel, Manuel organization: Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, 79106 Freiburg, Germany – sequence: 3 givenname: Vidisha Bhavesh orcidid: 0009-0000-3717-3245 surname: Patel fullname: Patel, Vidisha Bhavesh organization: Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, 79106 Freiburg, Germany – sequence: 4 givenname: Geoffroy orcidid: 0000-0002-5389-9481 surname: Andrieux fullname: Andrieux, Geoffroy organization: Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany – sequence: 5 givenname: Melanie surname: Boerries fullname: Boerries, Melanie organization: German Cancer Consortium (DKTK), Partner Site Freiburg, a Partnership between DKFZ and Medical Center-University of Freiburg, 79106 Freiburg, Germany – sequence: 6 givenname: Tatjana I surname: Cornu fullname: Cornu, Tatjana I organization: Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany – sequence: 7 givenname: Jamal orcidid: 0000-0003-4284-2006 surname: Alzubi fullname: Alzubi, Jamal organization: Center for Chronic Immunodeficiency (CCI), Medical Center-University of Freiburg, 79106 Freiburg, Germany – sequence: 8 givenname: Toni orcidid: 0000-0002-7757-4630 surname: Cathomen fullname: Cathomen, Toni organization: Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37947658$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk1v3CAQhq0qVZOmOfZaIfWQXpyCjT84pm6SRt1Vpe7eLQyDw8aGDeCD_1l_XnE3jZKqcADNPPPODMzb5MhYA0nynuCLPGf4s4Bh8CTLSFbU5FVykuEqTynF7OjZ_Tg5836H46pJSXDxJjnOK0arsqhPkl9NlEi_cA8Sra2EwSOr0HkzB3uvDaCfMEB0os1spLMjnKMrI62LluYrxSvEjUQ3jptpsGIOkK65cHZ_x_sI2MGaOd0EPU4DD9r06JqLYB36bqy4t1NA2qDmTo_gtECXJugeTMwoYL9QW7TU5hH3aK2jL0pYgzbB8QD9_C55rfjg4ezxPE2211fb5lu6-nFz21yuUkFZHlJWMpYBAclUjZkCkeOlcVZxUAxXHGcdYWwBgApMSVYrVksplKpKwUR-mtweZKXlu3bv9Mjd3Fqu2z8G6_qWu6DFAG2naC64pKLkHa1y1mVKZLJjjOO6AEqj1qeD1t7Zhwl8aEftly_kBuzk26yuWUaX0Ih-_Afd2cmZ2OhC1bgoKHlG9Tzm10bZ-DhiEW0vqyorclKXOFIX_6HiljBqEQdK6Wh_EZAeAuJXeu9APfVNcLvMXfti7iL_4bHYqRtBPtF_pyz_DZrZ1YA |
CitedBy_id | crossref_primary_10_1016_j_hlife_2024_06_002 crossref_primary_10_1055_a_2171_1422 crossref_primary_10_1080_14656566_2024_2340738 crossref_primary_10_3390_cimb46050288 |
Cites_doi | 10.3389/fimmu.2022.927153 10.1038/s41571-019-0297-y 10.1016/j.immuni.2016.10.026 10.1182/blood-2018-10-881722 10.1016/j.omtn.2023.04.024 10.1038/s41577-021-00547-6 10.1016/j.bbmt.2018.12.758 10.1016/j.ccell.2019.02.006 10.1186/s13046-021-02148-6 10.1016/j.stem.2021.02.002 10.1186/s40425-018-0343-9 10.1007/s12325-020-01397-9 10.1074/jbc.AC119.007558 10.1056/NEJMoa1709919 10.1016/S1470-2045(18)30864-7 10.1038/s41591-018-0041-7 10.3389/fgeed.2023.1130736 10.1056/NEJMra1706169 10.1089/hum.2021.165 10.1016/j.omtm.2020.12.008 10.1038/s41467-021-22417-4 10.1126/scitranslmed.aaj2013 10.1016/j.jaci.2023.08.003 10.1056/NEJMoa2116133 10.1158/0008-5472.CAN-14-3321 10.1016/j.omtm.2022.09.005 10.1182/blood.V71.4.997.997 10.1016/j.ymthe.2021.06.016 10.1089/crispr.2020.0022 10.1038/nrg.2016.28 10.1101/gr.171322.113 10.1038/s41591-018-0036-4 10.1038/mto.2016.11 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 MDPI AG 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: COPYRIGHT 2023 MDPI AG – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 8FD 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 GNUQQ HCIFZ LK8 M7P P64 PIMPY PQEST PQQKQ PQUKI PRINS RC3 7X8 DOA |
DOI | 10.3390/cells12212581 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic DOAJ - Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest Biological Science Collection ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Biological Science Database ProQuest SciTech Collection ProQuest Central China Biotechnology and BioEngineering Abstracts ProQuest Central Genetics Abstracts ProQuest One Academic UKI Edition Natural Science Collection ProQuest Central Korea Biological Science Collection Engineering Research Database ProQuest One Academic MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2073-4409 |
ExternalDocumentID | oai_doaj_org_article_bf43cad4c6ab4739b2fc2db99a085e44 A772531860 10_3390_cells12212581 37947658 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Germany St Louis Missouri United States--US |
GeographicLocations_xml | – name: Germany – name: St Louis Missouri – name: United States--US |
GrantInformation_xml | – fundername: German Academic Exchange Service grantid: scholarship 91686634 – fundername: German Federal Ministry of Education and Research grantid: EkoEstMed-01ZZ2015, MIRACUM-01ZZ1801B – fundername: European Union grantid: CARAT-667980, geneTIGA-101057438 |
GroupedDBID | 53G 5VS 8FE 8FH AADQD AAFWJ ABDBF ADBBV AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI CCPQU CGR CUY CVF DIK EBD ECM EIF ESX GROUPED_DOAJ HCIFZ HYE IAO IHR ITC KQ8 LK8 M48 M7P MODMG M~E NPM OK1 PGMZT PIMPY PROAC RIG RPM AAYXX CITATION 8FD ABUWG AZQEC DWQXO FR3 GNUQQ P64 PQEST PQQKQ PQUKI PRINS RC3 7X8 |
ID | FETCH-LOGICAL-c493t-96992e1ed9f809fec30765897aef907a02b199e1ede4c04128f98ddcff76c9c3 |
IEDL.DBID | M48 |
ISSN | 2073-4409 |
IngestDate | Thu Sep 05 15:29:26 EDT 2024 Fri Aug 16 06:24:27 EDT 2024 Thu Oct 10 20:09:34 EDT 2024 Wed Aug 14 18:50:45 EDT 2024 Tue Aug 13 05:21:24 EDT 2024 Fri Aug 23 02:02:29 EDT 2024 Tue Oct 15 08:48:13 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Keywords | CD40L knockout CRS GM-CSF CRISPR-Cas9 CD19-CAR T cells |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c493t-96992e1ed9f809fec30765897aef907a02b199e1ede4c04128f98ddcff76c9c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4284-2006 0000-0002-7757-4630 0009-0003-0073-1313 0009-0000-3717-3245 0000-0003-0741-2780 0000-0002-5389-9481 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/cells12212581 |
PMID | 37947658 |
PQID | 2888055419 |
PQPubID | 2032536 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_bf43cad4c6ab4739b2fc2db99a085e44 proquest_miscellaneous_2889244739 proquest_journals_2888055419 gale_infotracmisc_A772531860 gale_infotracacademiconefile_A772531860 crossref_primary_10_3390_cells12212581 pubmed_primary_37947658 |
PublicationCentury | 2000 |
PublicationDate | 2023-11-01 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Cells (Basel, Switzerland) |
PublicationTitleAlternate | Cells |
PublicationYear | 2023 |
Publisher | MDPI AG |
Publisher_xml | – name: MDPI AG |
References | Becher (ref_26) 2016; 45 Venkatesan (ref_34) 2023; 32 Locke (ref_4) 2022; 386 Kim (ref_20) 2014; 24 Markowicz (ref_15) 2012; 13 Bonafont (ref_33) 2022; 27 Amit (ref_22) 2021; 12 Locke (ref_24) 2019; 20 Kuhn (ref_28) 2019; 35 Rhiel (ref_19) 2023; 5 Alzubi (ref_16) 2021; 20 Zhang (ref_23) 2020; 37 Giavridis (ref_10) 2018; 24 June (ref_3) 2018; 379 Rafiq (ref_2) 2020; 17 Bloh (ref_17) 2021; 4 Sachdeva (ref_27) 2019; 294 Sterner (ref_14) 2019; 133 Tsai (ref_21) 2016; 17 Subklewe (ref_12) 2018; 6 Abken (ref_1) 2021; 32 Park (ref_9) 2018; 378 Norelli (ref_11) 2018; 24 Lee (ref_13) 2019; 25 Morris (ref_6) 2022; 22 Qasim (ref_30) 2017; 9 ref_29 Bonifant (ref_5) 2016; 3 Zhang (ref_7) 2022; 13 Chen (ref_25) 1988; 71 AlJanahi (ref_32) 2022; 30 Turchiano (ref_18) 2021; 28 Xiao (ref_8) 2021; 40 Poirot (ref_31) 2015; 75 |
References_xml | – volume: 13 start-page: 927153 year: 2022 ident: ref_7 article-title: CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.927153 contributor: fullname: Zhang – volume: 17 start-page: 147 year: 2020 ident: ref_2 article-title: Engineering strategies to overcome the current roadblocks in CAR T cell therapy publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/s41571-019-0297-y contributor: fullname: Rafiq – volume: 45 start-page: 963 year: 2016 ident: ref_26 article-title: GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation publication-title: Immunity doi: 10.1016/j.immuni.2016.10.026 contributor: fullname: Becher – volume: 133 start-page: 697 year: 2019 ident: ref_14 article-title: GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts publication-title: Blood doi: 10.1182/blood-2018-10-881722 contributor: fullname: Sterner – volume: 32 start-page: 671 year: 2023 ident: ref_34 article-title: Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies publication-title: Mol. Ther. Nucleic Acids doi: 10.1016/j.omtn.2023.04.024 contributor: fullname: Venkatesan – volume: 22 start-page: 85 year: 2022 ident: ref_6 article-title: Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-021-00547-6 contributor: fullname: Morris – volume: 25 start-page: 625 year: 2019 ident: ref_13 article-title: ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells publication-title: Biol. Blood Marrow Transplant. doi: 10.1016/j.bbmt.2018.12.758 contributor: fullname: Lee – volume: 35 start-page: 473 year: 2019 ident: ref_28 article-title: CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.02.006 contributor: fullname: Kuhn – volume: 40 start-page: 367 year: 2021 ident: ref_8 article-title: Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-021-02148-6 contributor: fullname: Xiao – volume: 13 start-page: 427 year: 2012 ident: ref_15 article-title: Adaptation of high-throughput screening in drug discovery-toxicological screening tests publication-title: Int. J. Mol. Sci. contributor: fullname: Markowicz – volume: 28 start-page: 1136 year: 2021 ident: ref_18 article-title: Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq publication-title: Cell Stem Cell doi: 10.1016/j.stem.2021.02.002 contributor: fullname: Turchiano – volume: 6 start-page: 56 year: 2018 ident: ref_12 article-title: Cytokine release syndrome publication-title: J. Immunother. Cancer doi: 10.1186/s40425-018-0343-9 contributor: fullname: Subklewe – volume: 37 start-page: 3040 year: 2020 ident: ref_23 article-title: A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible? publication-title: Adv. Ther. doi: 10.1007/s12325-020-01397-9 contributor: fullname: Zhang – volume: 294 start-page: 5430 year: 2019 ident: ref_27 article-title: Granulocyte–macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators publication-title: J. Biol. Chem. doi: 10.1074/jbc.AC119.007558 contributor: fullname: Sachdeva – volume: 378 start-page: 449 year: 2018 ident: ref_9 article-title: Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1709919 contributor: fullname: Park – volume: 20 start-page: 31 year: 2019 ident: ref_24 article-title: Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): A single-arm, multicentre, phase 1-2 trial publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(18)30864-7 contributor: fullname: Locke – volume: 24 start-page: 731 year: 2018 ident: ref_10 article-title: CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade publication-title: Nat. Med. doi: 10.1038/s41591-018-0041-7 contributor: fullname: Giavridis – volume: 5 start-page: 1130736 year: 2023 ident: ref_19 article-title: T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds publication-title: Front. Genome Ed. doi: 10.3389/fgeed.2023.1130736 contributor: fullname: Rhiel – volume: 379 start-page: 64 year: 2018 ident: ref_3 article-title: Chimeric Antigen Receptor Therapy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1706169 contributor: fullname: June – volume: 32 start-page: 1011 year: 2021 ident: ref_1 article-title: Building on Synthetic Immunology and T Cell Engineering: A Brief Journey through the History of Chimeric Antigen Receptors publication-title: Hum. Gene Ther. doi: 10.1089/hum.2021.165 contributor: fullname: Abken – volume: 20 start-page: 379 year: 2021 ident: ref_16 article-title: Automated generation of gene-edited CAR T cells at clinical scale publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2020.12.008 contributor: fullname: Alzubi – volume: 12 start-page: 3042 year: 2021 ident: ref_22 article-title: CRISPECTOR provides accurate estimation of genome editing translocation and off-target activity from comparative NGS data publication-title: Nat. Commun. doi: 10.1038/s41467-021-22417-4 contributor: fullname: Amit – volume: 9 start-page: eaaj2013 year: 2017 ident: ref_30 article-title: Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaj2013 contributor: fullname: Qasim – ident: ref_29 doi: 10.1016/j.jaci.2023.08.003 – volume: 386 start-page: 640 year: 2022 ident: ref_4 article-title: Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2116133 contributor: fullname: Locke – volume: 75 start-page: 3853 year: 2015 ident: ref_31 article-title: Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-3321 contributor: fullname: Poirot – volume: 27 start-page: 96 year: 2022 ident: ref_33 article-title: Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors publication-title: Mol. Ther. Methods Clin. Dev. doi: 10.1016/j.omtm.2022.09.005 contributor: fullname: Bonafont – volume: 71 start-page: 997 year: 1988 ident: ref_25 article-title: Granulocyte/macrophage colony-stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony-stimulating factor publication-title: Blood doi: 10.1182/blood.V71.4.997.997 contributor: fullname: Chen – volume: 30 start-page: 209 year: 2022 ident: ref_32 article-title: Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques publication-title: Mol. Ther. doi: 10.1016/j.ymthe.2021.06.016 contributor: fullname: AlJanahi – volume: 4 start-page: 120 year: 2021 ident: ref_17 article-title: Deconvolution of Complex DNA Repair (DECODR): Establishing a Novel Deconvolution Algorithm for Comprehensive Analysis of CRISPR-Edited Sanger Sequencing Data publication-title: CRISPR J. doi: 10.1089/crispr.2020.0022 contributor: fullname: Bloh – volume: 17 start-page: 300 year: 2016 ident: ref_21 article-title: Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases publication-title: Nat. Rev. Genet. doi: 10.1038/nrg.2016.28 contributor: fullname: Tsai – volume: 24 start-page: 1012 year: 2014 ident: ref_20 article-title: Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins publication-title: Genome Res. doi: 10.1101/gr.171322.113 contributor: fullname: Kim – volume: 24 start-page: 739 year: 2018 ident: ref_11 article-title: Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells publication-title: Nat. Med. doi: 10.1038/s41591-018-0036-4 contributor: fullname: Norelli – volume: 3 start-page: 16011 year: 2016 ident: ref_5 article-title: Toxicity and management in CAR T-cell therapy publication-title: Mol. Ther. Oncolytics doi: 10.1038/mto.2016.11 contributor: fullname: Bonifant |
SSID | ssj0000816105 |
Score | 2.3231716 |
Snippet | While chimeric antigen receptor (CAR) T cell therapy has shown promising outcomes among patients with hematologic malignancies, it has also been associated... |
SourceID | doaj proquest gale crossref pubmed |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 2581 |
SubjectTerms | Analysis Animal models Animals Antibodies Antigens Blood & organ donations CD19 antigen CD19-CAR T cells CD40 Ligand CD40L CD40L protein Cell activation Cell culture Cell therapy Cells Chimeric antigen receptors Colony-stimulating factor CRISPR CRISPR-Cas9 CRS Cytokine Release Syndrome Cytokines Cytolytic activity Drug dosages Genomes GM-CSF Granulocyte-macrophage colony-stimulating factor Granulocyte-Macrophage Colony-Stimulating Factor - genetics Granulocytes Humans Immunity Inflammation Interleukin 6 knockout Leukemia Lymphocytes Lymphocytes B Lymphocytes T Macrophages Malignancy Mice Mice, Knockout Monocytes Receptors, Chimeric Antigen - genetics Steroids T-Lymphocytes Testing Tumor antigens Tumor necrosis factor-TNF |
SummonAdditionalLinks | – databaseName: DOAJ - Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQJSQuiH8CBRkJwSkiP47XPm5DlwooB7pIvUWOf-iq4KAme8it78AFXoaH6ZMwY6erLhy4cI1nZccznvkmO_6GkOeFEMoyw1JjNE_x2myquBOpq9xMOgAgog3VFh_4wSf29rg6vtLqC2vCIj1w3DgsJCu1Mkxz1bJZKdvC6cK0UioAC5ZFJtC8upJMBR8sAMlkVSTVLCGvf4Xfwfu8AE9diXwrCAWu_r898h84M8SbxS1ycwKKdB4XeJtcs_4OuR5bR453ya8aZkr3IAYZiv3MvvS0c_Ti_Ec9Dt0pQEf6EQIKDNOjiZPg4vwn3femO4Nn9WuWvafKG_oGYtUaAto4gMD3Q4UdvU7Ax9AaJvJjejSsvoYOX_4zXYTePPSdBx_arQe68rQ-WYW_fOjcD8jrCbNinQxILSmusKeqp4erSOTReTqR4Y73yHKxv6wP0qkXQ6qZLIdUcikLm1sjnciksxp8A4AXOVPWQX6tsqLNpUQByzRyeAknBejfuRnXUpf3yY7vvH1IqGOQBbWAC7kSrNCstVxzbkwJnsPKNk_Ii0vdNN8i40YDmQoqsdlSYkL2UHMbISTKDg_AfJrJfJp_mU9CXqLeGzzOsANaTbcSYK1IjNXMIfsANyV4lpDdLUk4hnp7-NJymskN9A2cBJEBYMtlQp5thvGXWNrmbbcOMpAD49oS8iBa3OaVSvCWuM2P_serPiY3CkBo8SLlLtkZztb2CSCqoX0aDs9veckkLQ priority: 102 providerName: Directory of Open Access Journals – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagFRIXxD-BgoyE4BR1k3i99gnthl0qoBVqF6m3yPFPuwKcsskecus7cIGX4WH6JMwk3kULEtd4Ejse-5sZ_3xDyItUCGWZYbExmsd4bTZW3InYDd1IOnBARNmdtjjiB5_Yu9PhaVhwq8OxyjUmdkBtKo1r5PvwUTEA25fI1xffYswahburIYXGdbKbJgy3aXcn06OPx5tVFkwrAR5ET66ZQXy_j-vhdZICYg9FsmWMOs7-f5H5L3-zszuz2-RWcBjpuNfwHXLN-rvkRp9Csr1HfuVQUzwBW2Qo5jX7UtPK0avLH3nbVJ_BhaTHYFigmJ4EboKry5906k21hGf5Gzb4QJU39C3YrBUYtrYBge-HCjN7nQPW0Bwq8m180iy-dpm-_BmddTl66HsPWFqtGrrwND9fdFs_dOwb5PeEWvG8DEjNKbawpqqmh4ue0KPyNJDitvfJfDad5wdxyMkQayazJpZcytQm1kgnBtJZDRgBTowcKesgzlaDtEykRAHLNHJ5CScFjAPnRlxLnT0gO77y9hGhjkE0VIJ_yJVgqWal5ZpzYzJAECvLJCIv17opLnrmjQIiFlRisaXEiExQcxshJMzuHlTLsyLMv6J0LNPKMM1VyUaZLFOnU1NKqcDntIxF5BXqvcBpDT2gVbidAG1FgqxiDFEIwJXgg4jsbUnCdNTbxeuRUwQ4qIs_gzcizzfF-CYecfO2WnUyEAtj2yLysB9xm1_KADWxmx___-NPyM0UfLD-quQe2WmWK_sUfKamfBYmxm8pBhvr priority: 102 providerName: ProQuest |
Title | Cell-Based Models of 'Cytokine Release Syndrome' Endorse CD40L and Granulocyte-Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37947658 https://www.proquest.com/docview/2888055419 https://search.proquest.com/docview/2889244739 https://doaj.org/article/bf43cad4c6ab4739b2fc2db99a085e44 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELfQJiReEP8JG5WREDwF0sR17QeE2tAyAZ3Q1kl7ixz_2aptDrSpRN72HXiBL8OH2SfhLkmLynjkNb7Iju989zvH_h0hz2MhlGWGhcZoHuK12VBxJ0LXc33pAICIvD5tsc_3jtiH497xH0qhdgIX_0ztsJ7U0fz81bev1VtY8G8w44SU_TVucS-6MTjhHl7C3o5ZwtDYJy3Sr52yAGgT9RqWzetvbUSlmrz_uov-C3jWAWh8h9xukSMdNKq-S25Yf4_cbGpJVvfJrxR6CocQlAzFAmfnC1o4enX5I63K4gywJD2ACAPN9LAlKbi6_ElH3hRzeJa-Y9Enqryh7yF4LSHCVSUIfJ8oLPF1Ck6HptCRr8LDcnZRl_zyJ3RcF-uhHz041WJZ0pmn6ems_gdEB75Eok_oFQ_OgNSU4ggXVC3oZNYwexSetuy41QMyHY-m6V7YFmcINZNJGUouZWy71kgnIumsBmcBaEb2lXWQcKsozrtSooBlGkm9hJMCDMK5PtdSJw_Jli-8fUyoY5AW5QAUuRIs1iy3XHNuTAKuxMq8G5AXK91kXxoKjgxSF1RitqHEgAxRc2shZM6uHxTzk6xdiFnuWKKVYZqrnPUTmcdOxyaXUgH4tIwF5CXqPUOLgxnQqr2mAGNFpqxsAOkI-C3Bo4DsbkjCutSbzSvLyVZmncHSEBEguK4MyLN1M76JZ928LZa1DCTFOLaAPGosbv1JCbhPnOYn_-NTd8itGCBbc7Nyl2yV86V9ChCrzDtkezja_3zQqbcoOvVS-g3XjS2x |
link.rule.ids | 315,786,790,870,2115,2236,21416,24346,27955,27956,33777,33778,43838,74657 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NjtMwELagKwQXxO8SWMBICE7R5sdN7RNqQ0th2wrtFmlvkeOf3QpwliY99LbvwAVehofZJ2EmSYsKEtd4GqcZ-5tvHPsbQl5GnEvDNPO1VomPx2Z9mVju267tCQsEhOf1botZMv7EPpx2T9sFt7LdVrnBxBqodaFwjfwQbsoDiH2heHPxzceqUfh1tS2hcZ3soeQm75C9wXD28Xi7yoJlJYBBNOKaMeT3h7geXoYRIHaXhzvBqNbs_xeZ_-KbddwZ3SG3W8JI-42H75Jrxt0jN5oSkuv75FcKPfkDiEWaYl2zLyUtLL26_JGuq-IzUEh6DIEFmulJq01wdfmTDp0ulnAtfcuCCZVO03cQs1YQ2NYVGHyfSqzsdQ5YQ1PoyK39k2rxta705c7oqK7RQ48cYGmxqujC0fR8UX_6oX1Xob4n9Ir7ZcBqTvEJSypLOl00gh6Fo60o7voBmY-G83TstzUZfMVEXPkiESIyodHC8kBYowAjgMSInjQW8mwZRHkoBBoYplDLi1vBYRxY20uUUPFD0nGFM48ItQyyoRz4YSI5ixTLTaKSROsYEMSIPPTIq41vsotGeSODjAWdmO040SMD9NzWCAWz6wvF8ixr51-WWxYrqZlKZM56scgjqyKdCyGBcxrGPPIa_Z7htIY3oGR7OgGeFQWysj5kIQBXPAk8crBjCdNR7TZvRk7WwkGZ_Rm8HnmxbcZf4hY3Z4pVbQO5MD6bR_abEbf9SzGgJr7mx_-_-XNyczyfTrLJ-9nRE3IrAj7WHJs8IJ1quTJPgT9V-bN2kvwGvese4Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtNAEF5BKxAXxG8xFFgkBCcrsb3ZeE8ocRMKbaOqDVJv1np_2ghYl9g55NZ34AIvw8P0SZixN0EBiat37F17dr-ZWc9-Q8jrOE2lYZqFWise4rHZUHKbhrZn-8KCA5IWTbbFhO9_Yh_Pemc-_6nyaZUrTGyAWpcK98g78NC0C7YvEh3r0yKO98bvLr-FWEEK_7T6cho3yXaf8R4EYtvD0eT4ZL3jgiUmwJtoiTYTiPU7uDdeRTGgdy-NNgxTw9__L0r_5Xs2Nmh8j9z1ziMdtNq-T24Y94DcastJLh-SXxn0FA7BLmmKNc6-VLS09PrqR7asy8_gTtITMDLQTE89T8H11U86crqcw7Vsj3UPqXSavgf7tQAjt6xB4PuRxCpfF4A7NIOO3DI8rWdfm6pf7pyOm3o99MABrpaLms4czS5mzW8gOnA1cn1Cr5g7A1JTiiOsqKzo0awl9ygd9QS5y0dkOh5Ns_3Q12cIFRNJHQouRGwio4VNu8IaBXgBDo3oS2Mh5pbduIiEQAHDFPJ6pVakMCes7XMlVPKYbLnSmSeEWgaRUQG-IpcpixUrDFeca50AmhhRRAF5s9JNftmycOQQvaAS8w0lBmSImlsLIXl2c6Gcn-d-LeaFZYmSmikuC9ZPRBFbFetCCAn-p2EsIG9R7zkucfgCSvqTCjBWJMvKBxCRAHSlvBuQ3Q1JWJpqs3k1c3IPDVX-ZyIH5NW6Ge_EdDdnykUjA3Exji0gO-2MW79SAgiKn_np_x_-ktyG9ZEffpgcPCN3YnDN2hOUu2Srni_Mc3Cl6uKFXyO_AfgdIxU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell-Based+Models+of+%E2%80%98Cytokine+Release+Syndrome%E2%80%99+Endorse+CD40L+and+Granulocyte%E2%80%93Macrophage+Colony-Stimulating+Factor+Knockout+in+Chimeric+Antigen+Receptor+T+Cells+as+Mitigation+Strategy&rft.jtitle=Cells+%28Basel%2C+Switzerland%29&rft.au=Ala+Dibas&rft.au=Manuel+Rhiel&rft.au=Vidisha+Bhavesh+Patel&rft.au=Geoffroy+Andrieux&rft.date=2023-11-01&rft.pub=MDPI+AG&rft.eissn=2073-4409&rft.volume=12&rft.issue=21&rft.spage=2581&rft_id=info:doi/10.3390%2Fcells12212581&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bf43cad4c6ab4739b2fc2db99a085e44 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2073-4409&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2073-4409&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2073-4409&client=summon |